Quantum BioVenture Studio
ActiveSummary
Quantum BioVenture Studio has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €93k and a net result of €-94k. Its solvency ranks better than 17% of 190 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.2% (low).
Checked score
Score 2025
52
/ 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes
Profitability9
Solvency33
Growth-
Track record67
Bankruptcy probability, 12 months
1.2%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4.5k at 30 days acceptable
Liquidity ample (current ratio 2.41; short-term debt: 27.7% and cash: 46.4% of total assets), but 92.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 17% of 190 sector peers (2025).
NBB · sector comparisonPosition among 190 sector peers
Solvency
better than 17%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-06-2026, 46 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
46 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€-94k
Working capital
€463k
Balance-sheet composition
Assets €1.18M
Fixed assets
€390k
Current assets
€790k
Equity and liabilities €1.18M
Equity
€93k
Debt
€1.09M
Debt finances 92.1% of the balance-sheet total.
Key figures and ratios
EBITDA
€-75k
Cash flow
€-80k
Current ratio
2.41
Debt to equity
11.67
ROE
-101.4%
ROA
-8.0%
Interest coverage
-3.02
Debt ≤ 1 year
€327k
Debt > 1 year
€735k
Income taxes
€-14k
Filed annual accounts As filed with the NBB · 2025 · 38 lines
Balance sheet
Code2025
Assets
Total assets20/58€1.18M
Fixed assets21/28€390k
Intangible fixed assets21€390k
Current assets29/58€790k
Amounts receivable after more than one year29€14k
Other amounts receivable291€14k
Amounts receivable within one year40/41€228k
Other amounts receivable41€228k
Cash at bank and in hand54/58€547k
Deferred charges and accrued income490/1€2k
Equity and liabilities
Total equity and liabilities10/49€1.18M
Equity10/15€93k
Contributions10/11€20k
Profit (loss) carried forward14€-94k
Investment grants15€168k
Amounts payable17/49€1.09M
Amounts payable after more than one year17€735k
Financial debts170/4€735k
Amounts payable within one year42/48€327k
Trade debts44€71k
Suppliers440/4€71k
Taxes, remuneration and social security45€21
Taxes450/3€21
Other amounts payable47/48€256k
Accrued charges and deferred income492/3€24k
Income statement
Code2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€14k
Other operating charges640/8€832
Gross operating margin9900€-74k
Operating profit (loss)9901€-89k
Financial income75/76B€6k
Recurring financial income75€6k
Financial charges65/66B€25k
Recurring financial charges65€25k
Profit (loss) for the period before taxes9903€-108k
Income taxes67/77€-14k
Profit (loss) for the period9904€-94k
Profit (loss) for the period to be appropriated9905€-94k
Appropriation of the result
Profit (loss) to be appropriated9906€-94k
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2026
15-06
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
NBB filing
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wavre · 1 establishment unit since 2024
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Boulevard de l'Europe 131 D1300 WavreGround area
6,168 m²
Building footprint
2,304 m²
Volume, LiDAR
16,857 m³
Parcel 25006C0331/00N000, Wallonia · tallest building 12.8 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Boulevard de l'Europe 131D, 1300 Wavre
since 20242.357.674.971
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25006C0331/00N000 | Wallonia | 6,168 m² | 1 · 2,304 m² | 12.8 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
FluidDa
BE 0877.160.706
Kontich · Eq €93k
JAJA
BE 0844.607.704
Machelen (Brab.) · Eq €94k
BEWISE
BE 0828.876.480
Brugge · Eq €91k
HYDRICTIS
BE 1019.399.229
Clavier · Eq €96k
PROBIBEL
BE 0743.770.759
Antwerpen · Eq €97k
Of 761 companies in sector 72101 we hold annual accounts for 481. 287 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded28-03-2024
Fiscal year end31-12
Activities, NACEBEL 2025
72101Research and development on biotechnology
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
70200Business and other management consultancy
73300Public relations and communication consultancy
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 1 filingAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryE-mail:florence@bvi.eu